USPTO 2015–2025 USPTO PatentsView Foreign Corporation

K11 Group Limited

USPTO PatentsView assignee record - 15 granted patents across 0 technology areas, recorded in grant years 2017–2019. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength.

RSS updates for this company

The verdict

According to USPTO PatentsView, K11 ranks #18,798 of 49,997 tracked US assignees by granted-patent volume, with 15 patents across 0 technology areas.

#18,798
of 49,997 US assignees by volume
1st percentile
by Innovation Score (10.2/100)
1.0
avg claims per patent
-100%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R18798 · Foreign Corporation #18,798 · 15 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-UNK · INNOV-LOW · CLAIMS-SPARSE · TYPE-FRNCORP · VEL-DROP · BOOK-RICH

  • GRANTS-MICRO 15 grants
  • MID-PACK #18,798/49,997
  • PHOTO-FINISH Jazz Pharmaceuticals
  • CPC-UNK CPC blank
  • INNOV-LOW 10.2/100
  • CLAIMS-SPARSE 1.0 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-DROP -100% vel
  • BOOK-RICH 9/10 fields

Nearest grant-volume peer: Jazz Pharmaceuticals, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How K11’s 10.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around K11

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows K11's Innovation Score is 10.2/100 (1st percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for K11?

Each dot is one of K11’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). K11’s own 1.0 claims/patent is at or below the 16.3 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

K11 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 14.914.91515.1 0510152025 Granted patents (volume) Avg claims / patent Jazz Pharmaceuticals, Inc. - 15, 20.4Jazz Pharmaceutic…Jelli, LLC - 15, 20JelliJinda Films Americas LLC - 15, 19.33Jinda Films Ameri…Jostens, Inc. - 15, 8.07JostensK9 Sport Sack, LLC - 15, 5.8K9 Sport SackKB Medical, SA - 15, 16.07KB MedicalKing's Flair Development Ltd. - 15, 16.33King's Flair Deve…Kinik Company - 15, 16.87KinikK11 Group Limited - 15, 1K11 Group
K11 vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where K11's grants concentrate

K11 Group Limited is a focused PatentsView assignee: 0 CPC subclasses . Peak complete grant year is 2018 (7 grants) versus a trough of 3 in 2017. By volume, K11 sits between Jazz Pharmaceuticals, Inc. and Kinik Company.

Who files at K11's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows K11 holds 15 patents at rank #18,794, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near K11

By rank, the assignees closest to #18,794 in granted patent volume.

K11's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

10 1st percentile higher than 1% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

2345678 201720182019 5
USPTO utility patent grants by year · 2017–2019

Grants by year

Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.

View data table
K11 Group Limited patent grants by year, 2015–2025
Year Patents Granted Share of Period
2017 3 20.0%
2018 7 46.7%
2019 5 33.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

K11 Group Limited's patent record in context - here's where to go next.

  • Ranked #18,798 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare K11 Group Limited against Jazz Pharmaceuticals, Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 10.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.